Tower Research Capital LLC (TRC) - PLIANT THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of PLIANT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$159,008
+258.3%
9,170
+274.4%
0.01%
+400.0%
Q2 2023$44,376
+260935.3%
2,449
+271.6%
0.00%0.0%
Q1 2023$17
-46.9%
659
-59.7%
0.00%0.0%
Q4 2022$32
-100.0%
1,635
-69.8%
0.00%
-50.0%
Q3 2022$113,000
+352.0%
5,412
+73.3%
0.00%
+100.0%
Q2 2022$25,000
+56.2%
3,123
+37.6%
0.00%
Q1 2022$16,000
-27.3%
2,270
+39.3%
0.00%
Q4 2021$22,000
+100.0%
1,630
+130.6%
0.00%
Q3 2021$11,000
-76.1%
707
-55.6%
0.00%
-100.0%
Q2 2021$46,000
-24.6%
1,591
+2.2%
0.00%0.0%
Q1 2021$61,000
+110.3%
1,557
+24.4%
0.00%0.0%
Q4 2020$29,000
-71.0%
1,252
-71.7%
0.00%0.0%
Q3 2020$100,0004,4250.00%
Other shareholders
PLIANT THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 5,839,160$98,565,00018.71%
CHI Advisors LLC 2,484,724$41,942,00012.24%
TRV GP IV, LLC 2,132,867$36,003,0008.17%
Bond & Devick Financial Network, Inc. 120,160$2,028,0001.68%
Fernwood Investment Management, LLC 166,447$2,810,0000.96%
Redmile Group, LLC 3,083,501$52,049,0000.91%
HARVARD MANAGEMENT CO INC 562,379$9,493,0000.56%
Grace Capital 48,058$808,0000.50%
Eventide Asset Management 2,183,238$36,853,0000.49%
Cormorant Asset Management, LP 482,413$8,143,0000.33%
View complete list of PLIANT THERAPEUTICS INC shareholders